Evonik achieves biotech breakthrough with animal-free collagen
Evonik has announced the development of an advanced collagen platform that is made via fermentation-based processes and devoid of animal- or human-derived materials.
According to the company, the recombinant technology will, for the first time, provide pharmaceutical, medical, cell culture and tissue engineering markets with a highly soluble, ultra-pure form of collagen that is safe, sustainable and commercially scalable.
“This is arguably our biggest innovation breakthrough in recent years: a fermentation-based collagen platform that can effectively substitute the use of animal-derived collagen in pharmaceutical, medical, and cell culture markets.” said Dr. Thomas Riermeier, SVP and general manager for the Health Care business line of Evonik. “We look forward to working with customers to develop the next-generation collagen products with an improved safety profile.”
“Biotechnology is an important lever for growth and innovation within Evonik Nutrition & Care that leverages our core competencies across fermentation, biomaterials and product industrialisation,” said Johann-Caspar Gammelin, chairman of the Board of Management of Evonik Nutrition & Care.
The new collagen platform complements other recent fermentation-driven biotech breakthroughs by Evonik, including biosurfactants for household and cosmetic applications (rhamnolipids) and omega-3 fatty acids from natural marine algae for animal nutrition (Veramaris).
Evonik’s proprietary collagen platform features a triple helix structure and other biological properties that mimic many of the attributes of natural collagen so it can interact with cells and tissues and be readily absorbed or remodelled by the body.
Evonik’s collagen is produced under controlled conditions via a fermentation-based process. In addition to being sustainable and suitable for vegan use, this process delivers an ultra-high level of purity that is easily reproducible at any commercial scale.
Evonik will utilise its established fermentation process technologies and global manufacturing network to commercialize the collagen platform for worldwide use.